Yao et al. reported a decreased ratio of palmitoyl-carnitine to carnitine (C16-Carnitine/C0-Carnitine) in the papillary thyroid carcinoma group, indicating carnitine palmitoyl transferase I activity (Yao et al., 2011). Here, CPT1C is linked to thyroid gland papillary carcinoma.